Impact of COVID-19 on Sinus Augmentation Surgery
The Impact of COVID-19 on the Rate of Peri-operative Complications of Maxillary Sinus Floor Augmentation Procedure.
1 other identifier
interventional
24
1 country
1
Brief Summary
The risk of Schneiderian membrane perforation and the postoperative complications of the sinus floor elevation surgery were evaluated for patients with and without history of COVID-19 infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 20, 2023
CompletedFirst Submitted
Initial submission to the registry
July 22, 2023
CompletedFirst Posted
Study publicly available on registry
July 25, 2023
CompletedJuly 27, 2023
July 1, 2023
4 months
July 22, 2023
July 24, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Sinus membrane perforation
Intraoperative assessment of the incidence of sinus membrane perforation
Duration sinus lift
Study Arms (2)
Sinus lift in patients with previous COVID-19 infection
ACTIVE COMPARATORSinus floor augmentation in the posterior atrophic maxilla with delayed implant placement in patients with positive history of previous COVID-19 infection.
Sinus lift in patients with negative history of previous COVID
ACTIVE COMPARATORSinus floor augmentation in the posterior atrophic maxilla with delayed implant placement in patients with negative history of COVID-19 infection.
Interventions
Sinus augmentation in the posterior atrophic maxilla in patients with positive COVID-19 history
Sinus augmentation in the posterior atrophic maxilla in patients with negative COVID-19 history
Eligibility Criteria
You may qualify if:
- mm or less residual alveolar bone height
- Age more than 18 years
- Highly motivated patients
You may not qualify if:
- Patients who suffer from any systemic disease
- sinus pathosis other than sinusitis induced covid 19
- Patients under any medication that may interfere with the normal bone healing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of Dentistry, Cairo University
Cairo, 02, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Nahla Awadallah
Lecturer at Faculty of Dentistry, Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of oral and Maxillofacial Surgery
Study Record Dates
First Submitted
July 22, 2023
First Posted
July 25, 2023
Study Start
March 30, 2023
Primary Completion
July 15, 2023
Study Completion
July 20, 2023
Last Updated
July 27, 2023
Record last verified: 2023-07